Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SEC23B | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | TMEM5 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | HIST2H4B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | CYP2A13 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | CDC14A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | EFCAB5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | C19orf24 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | MYLK3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | MRPS35 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | STUB1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |